Berelowitz Michael 4
4 · Recro Pharma, Inc. · Filed May 8, 2018
Insider Transaction Report
Form 4
Berelowitz Michael
Director
Transactions
- Award
Stock Option (right to buy)
2018-05-04+5,742→ 5,742 totalExercise: $11.32Exp: 2028-05-04→ Common Stock (5,742 underlying) - Award
Common Stock
2018-05-04+6,183→ 6,183 total
Footnotes (2)
- [F1]All shares of common stock are represented by unvested restricted stock units that will vest on May 4, 2019. Vested shares will be delivered to the reporting person within 30 days following the vesting date.
- [F2]The stock option will vest on May 4, 2019.